Similar articles

Abstract: Objective: To investigate gene mutations associated with three different types of corneal dystrophies (CDs), and to establish a phenotype-genotype correlation. Methods: Two patients with Avellino corneal dystrophy (ACD), four patients with lattice corneal dystrophy type I (LCD I) from one family, and three patients with macular corneal dystrophy type I (MCD I) were subjected to both clinical and genetic examinations. Slit lamp examination was performed for all the subjects to assess their corneal phenotypes. Genomic DNA was extracted from peripheral blood leukocytes. The coding regions of the human transforming growth factor β-induced (TGFBI) gene and carbohydrate sulfotransferase 6 (CHST6) gene were amplified by polymerase chain reaction (PCR) and subjected to direct sequencing. DNA samples from 50 healthy volunteers were used as controls. Results: Clinical examination showed three different phenotypes of CDs. Genetic examination identified that two ACD subjects were associated with homozygous R124H mutation of TGFBI, and four LCD I subjects were all associated with R124C heterozygous mutation. One MCD I subject was associated with a novel S51X homozygous mutation in CHST6, while the other two MCD I subjects harbored a previously reported W232X homozygous mutation. Conclusions: Our study highlights the prevalence of codon 124 mutations in the TGFBI gene among the Chinese ACD and LCD I patients. Moreover, we found a novel mutation among MCD I patients.

[1]Akama, T.O., Nishida, K., Nakayama, J., Watanabe, H., Ozaki, K., Nakamura, T., Dota, A., Kawasaki, S., Inoue, Y., Maeda, N., et al., 2000. Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene. Nat. Genet., 26(2):237-241.

[2]Cao, W., Ge, H., Cui, X., Zhang, L., Bai, J., Fu, S., Liu, P., 2009. Reduced penetrance in familial Avellino corneal dystrophy associated with TGFBI mutations. Mol. Vis., 15:70-75.

[3]Fujiki, K., Hotta, Y., Nakayasu, K., Kanai, A., 1998. Homozygotic patient with βig-h3 gene mutation in granular dystrophy. Cornea, 17(3):288-292.

[4]Grimberg, J., Nawoschik, S., Belluscio, L., McKee, R., Turck, A., Eisenberg, A., 1989. A simple and efficient non-organic procedure for the isolation of genomic DNA from blood. Nucleic. Acids Res., 17(20):8390.

[5]Ha, N.T., Chau, H.M., Cung, L.X., Thanh, T.K., Fujiki, K., Murakami, A., Hiratsuka, Y., Hasegawa, N., Kanai, A., 2003a. Identification of novel mutations of the CHST6 gene in Vietnamese families affected with macular corneal dystrophy in two generations. Cornea, 22(6):508-511.

[6]Ha, N.T., Chau, H.M., Cung, L.X., Thanh, T.K., Fujiki, K., Murakami, A., Hiratsuka, Y., Kanai, A., 2003b. Mutation analysis of the carbohydrate sulfotransferase gene in Vietnamese with macular corneal dystrophy. Invest. Ophthalmol. Vis. Sci., 44(8):3310-3316.

[7]Hassell, J.R., Klintworth, G.K., 1997. Serum sulfotransferase levels in patients with macular corneal dystrophy type I. Arch. Ophthalmol., 115(11):1419-1421.

[8]Huerva, V., Velasco, A., Sanchez, M.C., Matias-Guiu, X., 2008. Role of BIGH3 R124H mutation in the diagnosis of Avellino corneal dystrophy. Eur. J. Ophthalmol., 18(3):345-350.

[9]Jonasson, F., Oshima, E., Thonar, E.J., Smith, C.F., Johannsson, J.H., Klintworth, G.K., 1996. Macular corneal dystrophy in Iceland. A clinical, genealogic, and immunohistochemical study of 28 patients. Ophthalmology, 103(7):1111-1117.

[10]Klintworth, G.K., 1980. Research into the pathogenesis of macular corneal dystrophy. Trans. Ophthalmol. Soc. UK, 100(Pt 1):186-194.

[11]Klintworth, G.K., Oshima, E., al-Rajhi, A., al-Saif, A., Thonar, E.J., Karcioglu, Z.A., 1997. Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype. Am. J. Ophthalmol., 124(1):9-18.

[12]Klintworth, G.K., Bao, W., Afshari, N.A., 2004. Two mutations in the TGFBI (BIGH3) gene associated with lattice corneal dystrophy in an extensively studied family. Invest. Ophthalmol. Vis. Sci., 45(5):1382-1388.

[13]Klintworth, G.K., Smith, C.F., Bowling, B.L., 2006. CHST6 mutations in North American subjects with macular corneal dystrophy: a comprehensive molecular genetic review. Mol. Vis., 12:159-176.

[14]Korvatska, E., Munier, F.L., Chaubert, P., Wang, M.X., Mashima, Y., Yamada, M., Uffer, S., Zografos, L., Schorderet, D.F., 1999. On the role of kerato-epithelin in the pathogenesis of 5q31-linked corneal dystrophies. Invest. Ophthalmol. Vis. Sci., 40(10):2213-2219.

[15]Moon, J.W., Kim, S.W., Kim, T.I., Cristol, S.M., Chung, E.S., Kim, E.K., 2007. Homozygous granular corneal dystrophy type II (Avellino corneal dystrophy): natural history and progression after treatment. Cornea, 26(9):1095-1100.

[16]Munier, F.L., Korvatska, E., Djemai, A., Le Paslier, D., Zografos, L., Pescia, G., Schorderet, D.F., 1997. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat. Genet., 15(3):247-251.

[17]Okada, M., Yamamoto, S., Inoue, Y., Watanabe, H., Maeda, N., Shimomura, Y., Ishii, Y., Tano, Y., 1998. Severe corneal dystrophy phenotype caused by homozygous R124H keratoepithelin mutations. Invest. Ophthalmol. Vis. Sci., 39(10):1947-1953.

[18]Skonier, J., Neubauer, M., Madisen, L., Bennett, K., Plowman, G.D., Purchio, A.F., 1992. cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β. DNA Cell Biol., 11(7):511-522.

[19]Sultana, A., Sridhar, M.S., Jagannathan, A., Balasubramanian, D., Kannabiran, C., Klintworth, G.K., 2003. Novel mutations of the carbohydrate sulfotransferase-6 (CHST6) gene causing macular corneal dystrophy in India. Mol. Vis., 9:730-734.

[20]Tsujikawa, K., Tsujikawa, M., Watanabe, H., Maeda, N., Inoue, Y., Fujikado, T., Tano, Y., 2007. Allelic homogeneity in Avellino corneal dystrophy due to a founder effect. J. Hum. Genet., 52(1):92-97.

[21]Vance, J.M., Jonasson, F., Lennon, F., Sarrica, J., Damji, K.F., Stauffer, J., Pericak-Vance, M.A., Klintworth, G.K., 1996. Linkage of a gene for macular corneal dystrophy to chromosome 16. Am. J. Hum. Genet., 58(4):757-762.

[22]Warren, J.F., Aldave, A.J., Srinivasan, M., Thonar, E.J., Kumar, A.B., Cevallos, V., Whitcher, J.P., Margolis, T.P., 2003. Novel mutations in the CHST6 gene associated with macular corneal dystrophy in southern India. Arch. Ophthalmol., 121(11):1608-1612.

[23]Yao, Y.F., 2008. A novel technique for performing full-bed deep lamellar keratoplasty. Cornea, 27(Suppl. 1):S19-S24.

[24]Yao, Y.F., Jin, Y.Q., Zhang, B., Zhou, P., Zhang, Y.M., Qiu, W.Y., Mou, S.L., Wu, L.Q., 2006. Recurrence of lattice corneal dystrophy caused by incomplete removal of stroma after deep lamellar keratoplasty. Cornea, 25(10 Suppl. 1):S41-S46.

[25]Yoshida, S., Kumano, Y., Yoshida, A., Hisatomi, T., Matsui, H., Nishida, T., Ishibashi, T., Matsui, T., 2002. An analysis of BIGH3 mutations in patients with corneal dystrophies in the Kyushu district of Japan. Jpn J. Ophthalmol., 46(4):469-471.

[26]Yu, J., Zou, L.H., He, J.C., Liu, N.P., Zhang, W., Lu, L., Sun, X.G., Dong, D.S., Wu, Y.Y., Yin, X.T., 2003. Analysis of mutation of BIGH3 gene in Chinese patients with corneal dystrophies. Chin. J. Ophthalmol., 39(10):582-586 (in Chinese).

[27]Yu, P., Gu, Y., Yang, Y., Yan, X., Chen, L., Ge, Z., Qi, M., Si, J., Guo, L., 2006. A clinical and molecular-genetic analysis of Chinese patients with lattice corneal dystrophy and novel Thr538Pro mutation in the TGFBI (BIGH3) gene. J. Genet., 85(1):73-76.

[28]Yu, P., Gu, Y., Jin, F., Hu, R., Chen, L., Yan, X., Yang, Y., Qi, M., 2008. p.Ala546>Asp and p.Arg555>Trp mutations of TGFBI gene and their clinical manifestations in two large Chinese families with granular corneal dystrophy type I. Genet. Test, 12(3):421-425.